Drug intelligence / Profile preview

Gusongling tincture

Development stage: Unknown
Lead developer: West China Hospital of Sichuan University
Administration: Topical

Overview

Gusongling tincture is a multi-ingredient traditional Chinese topical tincture used for musculoskeletal and joint-pain conditions. The identified product contains xueshangyizhihao, dried ginger, dragon's blood resin, frankincense, myrrh, and borneol, with ethanol as an excipient. Its clinical pharmacology has not been defined by a validated single molecular target; it is intended to provide local analgesic and anti-inflammatory effects in traditional use. A prospectively registered ChiCTR study evaluates Gusongling tincture combined with oral meloxicam in patients with knee osteoarthritis. ([drugs.dxy.cn](https://drugs.dxy.cn/pc/search?keyword=%E9%AA%A8%E7%97%9B%E7%81%B5%E9%85%8A))

Brand names: Kangkuai
Other names: Gutongling tinctureGu tong ling ding骨痛灵酊

Beyond the preview

Go deeper on Gusongling tincture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gusongling tincture.

Explore the full profile